Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.

Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.

PLoS One. 2020 Feb 12;15(2):e0228909. doi: 10.1371/journal.pone.0228909. eCollection 2020.

2.

A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer.

Torres S, González Á, Cunquero Tomas AJ, Calabuig Fariñas S, Ferrero M, Mirda D, Sirera R, Jantus-Lewintre E, Camps C.

Expert Rev Mol Diagn. 2020 Feb 3. doi: 10.1080/14737159.2020.1724094. [Epub ahead of print]

PMID:
32011193
3.

Treatment patterns for metastatic colorectal cancer in Spain.

Aranda E, Polo E, Camps C, Carrato A, Díaz-Rubio E, Guillem V, López R, Antón A.

Clin Transl Oncol. 2020 Jan 23. doi: 10.1007/s12094-019-02279-5. [Epub ahead of print]

PMID:
31974819
4.

Outcome of Silicone Implant for Treatment After Failure of Primary Trapeziometacarpal Surgery.

Lallemand B, Cheval D, Camps C, Merle M, Jager T.

J Hand Surg Am. 2019 Dec 6. pii: S0363-5023(19)31420-0. doi: 10.1016/j.jhsa.2019.09.013. [Epub ahead of print]

PMID:
31818540
5.

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.

Villalba M, Exposito F, Pajares MJ, Sainz C, Redrado M, Remirez A, Wistuba I, Behrens C, Jantus-Lewintre E, Camps C, Montuenga LM, Pio R, Lozano MD, de Andrea C, Calvo A.

J Clin Med. 2019 Dec 3;8(12). pii: E2134. doi: 10.3390/jcm8122134.

6.

Electrophysiological assessment of plant status outside a Faraday cage using supervised machine learning.

Tran D, Dutoit F, Najdenovska E, Wallbridge N, Plummer C, Mazza M, Raileanu LE, Camps C.

Sci Rep. 2019 Nov 19;9(1):17073. doi: 10.1038/s41598-019-53675-4.

7.

The gynoecious CmWIP1 transcription factor interacts with CmbZIP48 to inhibit carpel development.

Eleblu JSY, Haraghi A, Mania B, Camps C, Rashid D, Morin H, Dogimont C, Boualem A, Bendahmane A.

Sci Rep. 2019 Oct 28;9(1):15443. doi: 10.1038/s41598-019-52004-z.

8.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

Villalba M, Redin E, Exposito F, Pajares MJ, Sainz C, Hervas D, Guruceaga E, Diaz-Lagares A, Cirauqui C, Redrado M, Valencia K, de Andrea C, Jantus-Lewintre E, Camps C, Lopez-Lopez R, Lahoz A, Montuenga L, Pio R, Sandoval J, Calvo A.

Sci Rep. 2019 Oct 28;9(1):15400. doi: 10.1038/s41598-019-51066-3.

9.

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study).

Provencio M, Carcereny E, Rodríguez-Abreu D, López-Castro R, Guirado M, Camps C, Bosch-Barrera J, García-Campelo R, Ortega-Granados AL, González-Larriba JL, Casal-Rubio J, Domine M, Massutí B, Sala MÁ, Bernabé R, Oramas J, Del Barco E.

Transl Lung Cancer Res. 2019 Aug;8(4):461-475. doi: 10.21037/tlcr.2019.08.05.

10.

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer.

Herreros-Pomares A, de-Maya-Girones JD, Calabuig-Fariñas S, Lucas R, Martínez A, Pardo-Sánchez JM, Alonso S, Blasco A, Guijarro R, Martorell M, Escorihuela E, Chiara MD, Duréndez E, Gandía C, Forteza J, Sirera R, Jantus-Lewintre E, Farràs R, Camps C.

Cell Death Dis. 2019 Sep 10;10(9):660. doi: 10.1038/s41419-019-1898-1.

11.

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

Isla D, De Las Peñas R, Insa A, Marsé R, Martínez-Banaclocha N, Mut P, Morán T, Sala MÁ, Massuti B, Ortega AL, Jurado JM, Gómez-Codina J, Diz P, Artal Á, Gutiérrez V, Vázquez MF, Viñolas N, Maestu I, Camps C, Álvarez R, de Mon Soto MÁ, Ponce S, Provencio M.

Lung Cancer. 2019 Sep;135:161-168. doi: 10.1016/j.lungcan.2018.11.041. Epub 2018 Dec 1.

PMID:
31446990
12.

The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.

Schwarze K, Buchanan J, Fermont JM, Dreau H, Tilley MW, Taylor JM, Antoniou P, Knight SJL, Camps C, Pentony MM, Kvikstad EM, Harris S, Popitsch N, Pagnamenta AT, Schuh A, Taylor JC, Wordsworth S.

Genet Med. 2020 Jan;22(1):85-94. doi: 10.1038/s41436-019-0618-7. Epub 2019 Jul 30.

13.

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance.

Zugazagoitia J, Gómez-Rueda A, Jantus-Lewintre E, Isla D, Camps C, Ramos I, Trigo JM, Bernabé R, Juan-Vidal O, Sanchez-Torres JM, García-Campelo R, Provencio M, Felip E, de Castro J, Faull I, Lanman RB, Ponce-Aix S, Paz-Ares L, Garrido P.

Lung Cancer. 2019 Aug;134:72-78. doi: 10.1016/j.lungcan.2019.05.032. Epub 2019 May 30.

PMID:
31319999
14.

Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.

Cunquero-Tomás AJ, Ávila-Andrade CD, Milara J, Javier K, Iranzo V, Camps C.

J Oncol Pharm Pract. 2020 Mar;26(2):492-495. doi: 10.1177/1078155219858173. Epub 2019 Jul 1.

PMID:
31260379
15.

How sustainable are new treatment strategies for NSCLC?

Remon J, Lopes G, Camps C.

Lancet Respir Med. 2019 Sep;7(9):733-735. doi: 10.1016/S2213-2600(19)30184-5. Epub 2019 Jun 14. No abstract available. Erratum in: Lancet Respir Med. 2019 Sep;7(9):e28.

PMID:
31208953
16.

Optimized Prediction of Reducing Sugars and Dry Matter of Potato Frying by FT-NIR Spectroscopy on Peeled Tubers.

Camps C, Camps ZN.

Molecules. 2019 Mar 9;24(5). pii: E967. doi: 10.3390/molecules24050967.

17.

A translational approach to design effective intervention tools for informal caregivers of dependent cancer patients.

Bonacasa MD, Rosa E, Camps C, Martínez-Rubio D.

Public Health. 2019 Mar;168:50-58. doi: 10.1016/j.puhe.2018.11.013. Epub 2019 Jan 24.

PMID:
30685599
18.

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.

Zugazagoitia J, Ramos I, Trigo JM, Palka M, Gómez-Rueda A, Jantus-Lewintre E, Camps C, Isla D, Iranzo P, Ponce-Aix S, García-Campelo R, Provencio M, Franco F, Bernabé R, Juan-Vidal O, Felip E, de Castro J, Sanchez-Torres JM, Faul I, Lanman RB, Garrido P, Paz-Ares L.

Ann Oncol. 2019 Feb 1;30(2):290-296. doi: 10.1093/annonc/mdy512.

19.

Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.

Karachaliou N, Bracht JWP, Fernandez Bruno M, Drozdowskyj A, Gimenez Capitan A, Moran T, Carcereny E, Cobo M, Domine M, Chaib I, Ramirez JL, Camps C, Provencio M, Vergnenegre A, Lopez-Vivanco G, Majem M, Massuti B, Rosell R.

J Thorac Oncol. 2019 Feb;14(2):304-310. doi: 10.1016/j.jtho.2018.10.168. Epub 2018 Nov 22.

20.

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.

García-Foncillas J, Tabernero J, Élez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, López R, Muinelo-Romay L, Montagut C, Antón A, López G, Díaz-Rubio E, Rojo F, Vivancos A.

Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

21.

The burden of cancer in Spain.

Badía X, Tort M, Manganelli AG, Camps C, Díaz-Rubio E.

Clin Transl Oncol. 2019 Jun;21(6):729-734. doi: 10.1007/s12094-018-1972-7. Epub 2018 Nov 9.

PMID:
30414063
22.

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.

Galván-Femenía I, Guindo M, Duran X, Calabuig-Fariñas S, Mercader JM, Ramirez JL, Rosell R, Torrents D, Carreras A, Kohno T, Jantus-Lewintre E, Camps C, Perucho M, Sumoy L, Yokota J, de Cid R.

Cancer Treat Res Commun. 2018;15:21-31. doi: 10.1016/j.ctarc.2018.02.003. Epub 2018 Mar 1.

23.

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.

Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D, Kerr R, Sieber O, Taylor JC, Tomlinson I.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):635-643. doi: 10.1016/S2468-1253(18)30117-1. Epub 2018 Jul 2.

24.

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.

Lenglet M, Robriquet F, Schwarz K, Camps C, Couturier A, Hoogewijs D, Buffet A, Knight SJL, Gad S, Couvé S, Chesnel F, Pacault M, Lindenbaum P, Job S, Dumont S, Besnard T, Cornec M, Dreau H, Pentony M, Kvikstad E, Deveaux S, Burnichon N, Ferlicot S, Vilaine M, Mazzella JM, Airaud F, Garrec C, Heidet L, Irtan S, Mantadakis E, Bouchireb K, Debatin KM, Redon R, Bezieau S, Bressac-de Paillerets B, Teh BT, Girodon F, Randi ML, Putti MC, Bours V, Van Wijk R, Göthert JR, Kattamis A, Janin N, Bento C, Taylor JC, Arlot-Bonnemains Y, Richard S, Gimenez-Roqueplo AP, Cario H, Gardie B.

Blood. 2018 Aug 2;132(5):469-483. doi: 10.1182/blood-2018-03-838235. Epub 2018 Jun 11.

25.

This is a call to oncologists for action.

Micó C, Berrocal A, Blasco A, Caballero C, Iranzo V, Lobo M, Camps C.

Clin Transl Oncol. 2018 Dec;20(12):1493-1501. doi: 10.1007/s12094-018-1887-3. Epub 2018 May 23. Review.

PMID:
29796999
26.

About the article: Abi-Chahla M.-L., Alet J.-M., Fabre T., Pelissier P. Fig. 1. Treatment of defects in the tip and palmar surface of the fingers. Hand Surg Rehabil 2018;37:4-11.

Pomares G, Duysens C, Camps C, Durand A, Falcone A, Jager T.

Hand Surg Rehabil. 2018 May 14. pii: S2468-1229(18)30059-8. doi: 10.1016/j.hansur.2018.04.001. [Epub ahead of print] No abstract available.

PMID:
29773461
27.

EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.

Herreros-Pomares A, Aguilar-Gallardo C, Calabuig-Fariñas S, Sirera R, Jantus-Lewintre E, Camps C.

Crit Rev Oncol Hematol. 2018 Jun;126:52-63. doi: 10.1016/j.critrevonc.2018.03.006. Epub 2018 Mar 21. Review.

PMID:
29759567
28.

The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Laes JF, Aftimos P, Barthelemy P, Bellmunt J, Berchem G, Camps C, Peñas RL, Finzel A, García-Foncillas J, Hervonen P, Wahid I, Joensuu T, Kathan L, Kong A, Mackay J, Mikropoulos C, Mokbel K, Mouysset JL, Odarchenko S, Perren TJ, Pienaar R, Regonesi C, Alkhayyat SS, El Kinge AR, Abulkhair O, Galal KM, Ghanem H, El Karak F, Garcia A, Ghitti G, Sadik H.

Oncotarget. 2018 Apr 17;9(29):20282-20293. doi: 10.18632/oncotarget.24757. eCollection 2018 Apr 17.

29.

Sweet syndrome as the leading symptom in the diagnosis of gastric cancer.

Cunquero-Tomás AJ, Ortiz-Salvador JM, Iranzo V, Camps C.

Chin Clin Oncol. 2018 Feb;7(1):11. doi: 10.21037/cco.2018.01.07.

30.

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients.

Provencio M, Torrente M, Calvo V, Pérez-Callejo D, Gutiérrez L, Franco F, Pérez-Barrios C, Barquín M, Royuela A, García-García F, Bueno C, Garcia-Grande A, Camps C, Massuti B, Sotomayor E, Romero A.

Oncotarget. 2017 Nov 16;9(1):488-494. doi: 10.18632/oncotarget.22470. eCollection 2018 Jan 2.

31.

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Ajona D, Zandueta C, Corrales L, Moreno H, Pajares MJ, Ortiz-Espinosa S, Martínez-Terroba E, Perurena N, de Miguel FJ, Jantus-Lewintre E, Camps C, Vicent S, Agorreta J, Montuenga LM, Pio R, Lecanda F.

Am J Respir Crit Care Med. 2018 May 1;197(9):1164-1176. doi: 10.1164/rccm.201703-0660OC.

32.
33.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

34.

New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.

Duréndez-Sáez E, Azkárate A, Meri M, Calabuig-Fariñas S, Aguilar-Gallardo C, Blasco A, Jantus-Lewintre E, Camps C.

J Thorac Dis. 2017 Oct;9(Suppl 13):S1332-S1345. doi: 10.21037/jtd.2017.06.112. Review.

35.

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value.

Gallach S, Jantus-Lewintre E, Calabuig-Fariñas S, Montaner D, Alonso S, Sirera R, Blasco A, Usó M, Guijarro R, Martorell M, Camps C.

Oncotarget. 2017 Jun 22;8(34):56143-56157. doi: 10.18632/oncotarget.18603. eCollection 2017 Aug 22.

36.

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions.

Mayo-de-Las-Casas C, Jordana-Ariza N, Garzón-Ibañez M, Balada-Bel A, Bertrán-Alamillo J, Viteri-Ramírez S, Reguart N, Muñoz-Quintana MA, Lianes-Barragan P, Camps C, Jantús E, Remon-Massip J, Calabuig S, Aguiar D, Gil ML, Viñolas N, Santos-Rodríguez AK, Majem M, García-Peláez B, Villatoro S, Pérez-Rosado A, Monasterio JC, Ovalle E, Catalán MJ, Campos R, Morales-Espinosa D, Martínez-Bueno A, González-Cao M, González X, Moya-Horno I, Sosa AE, Karachaliou N, Rosell R, Molina-Vila MA.

Ann Oncol. 2017 Sep 1;28(9):2248-2255. doi: 10.1093/annonc/mdx288.

37.

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

Aapro M, Boccia R, Leonard R, Camps C, Campone M, Choquet S, Danova M, Glaspy J, Hus I, Link H, Sliwa T, Tesch H, Valero V.

Support Care Cancer. 2017 Nov;25(11):3295-3304. doi: 10.1007/s00520-017-3842-1. Epub 2017 Aug 25. Review.

38.

The quest for epigenetic regulation underlying unisexual flower development in Cucumis melo.

Latrasse D, Rodriguez-Granados NY, Veluchamy A, Mariappan KG, Bevilacqua C, Crapart N, Camps C, Sommard V, Raynaud C, Dogimont C, Boualem A, Benhamed M, Bendahmane A.

Epigenetics Chromatin. 2017 Jun 6;10:22. doi: 10.1186/s13072-017-0132-6. eCollection 2017.

39.

Drawing Links from Transcriptome to Metabolites: The Evolution of Aroma in the Ripening Berry of Moscato Bianco (Vitis vinifera L.).

Costantini L, Kappel CD, Trenti M, Battilana J, Emanuelli F, Sordo M, Moretto M, Camps C, Larcher R, Delrot S, Grando MS.

Front Plant Sci. 2017 May 16;8:780. doi: 10.3389/fpls.2017.00780. eCollection 2017.

40.

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.

Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R, Aix SP, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, Bidoli P, Favaretto A, Froesch P, Reguart N, Puente J, Coate L, Barlesi F, Rauch D, Thomas M, Camps C, Gómez-Codina J, Majem M, Porta R, Shah R, Hanrahan E, Kammler R, Ruepp B, Rabaglio M, Kassapian M, Karachaliou N, Tam R, Shames DS, Molina-Vila MA, Stahel RA; BELIEF collaborative group.

Lancet Respir Med. 2017 May;5(5):435-444. doi: 10.1016/S2213-2600(17)30129-7. Epub 2017 Apr 10. Erratum in: Lancet Respir Med. 2018 Dec;6(12):e57.

PMID:
28408243
41.

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.

Usó M, Jantus-Lewintre E, Calabuig-Fariñas S, Blasco A, García Del Olmo E, Guijarro R, Martorell M, Camps C, Sirera R.

Oncoimmunology. 2016 Dec 7;6(1):e1260214. doi: 10.1080/2162402X.2016.1260214. eCollection 2017.

42.

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Hamblin A, Wordsworth S, Fermont JM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, Henderson S, Cutts A, Vavoulis DV, Housby N, Tomlinson I, Taylor JC, Schuh A.

PLoS Med. 2017 Feb 14;14(2):e1002230. doi: 10.1371/journal.pmed.1002230. eCollection 2017 Feb.

43.

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.

Malapelle U, Sirera R, Jantus-Lewintre E, Reclusa P, Calabuig-Fariñas S, Blasco A, Pisapia P, Rolfo C, Camps C.

Expert Rev Mol Diagn. 2017 Mar;17(3):209-215. doi: 10.1080/14737159.2017.1288568. Epub 2017 Feb 9. Review. Erratum in: Expert Rev Mol Diagn. 2017 Mar;17 (3):i.

PMID:
28129709
44.

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.

Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.

Clin Transl Oncol. 2017 Jun;19(6):651-657. doi: 10.1007/s12094-016-1599-5. Epub 2017 Jan 4. Review.

PMID:
28054319
45.

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R; Spanish Lung Cancer Group.

Clin Lung Cancer. 2017 Mar;18(2):178-188.e4. doi: 10.1016/j.cllc.2016.08.007. Epub 2016 Nov 9.

PMID:
27908619
46.

[Treatment of partial articular fractures of the distal radius in active young adults].

Camps C, Durand A, Merle M.

Hand Surg Rehabil. 2016 Dec;35S:S126-S132. doi: 10.1016/j.hansur.2016.07.008. Epub 2016 Oct 24. Review. French.

PMID:
27890197
47.

[Treatment of intra-articular malunion of the distal radius of young active patients].

Durand A, Camps C, Merle M.

Hand Surg Rehabil. 2016 Dec;35S:S105-S111. doi: 10.1016/j.hansur.2016.03.009. Epub 2016 Oct 13. French.

PMID:
27890193
48.

Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Calabuig-Fariñas S, Jantus-Lewintre E, Herreros-Pomares A, Camps C.

Transl Lung Cancer Res. 2016 Oct;5(5):466-482. Review.

49.

Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Camps C, Petousi N, Bento C, Cario H, Copley RR, McMullin MF, van Wijk R, Ratcliffe PJ, Robbins PA, Taylor JC; WGS500 Consortium.

Haematologica. 2016 Nov;101(11):1306-1318. Epub 2016 Sep 20.

50.

Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.

Kaisaki PJ, Cutts A, Popitsch N, Camps C, Pentony MM, Wilson G, Page S, Kaur K, Vavoulis D, Henderson S, Gupta A, Middleton MR, Karydis I, Talbot DC, Schuh A, Taylor JC.

PLoS One. 2016 Sep 14;11(9):e0162809. doi: 10.1371/journal.pone.0162809. eCollection 2016.

Supplemental Content

Support Center